FDA Inspection 1012873 — Coriell Institue for Medical Research
The FDA completed an inspection of Coriell Institue for Medical Research on April 27, 2017 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 27, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Camden, NJ (United States)